GenVec Inc (GNVC) - Financial and Strategic SWOT Analysis Review

July 2017 | 41 pages | ID: G37985238C2EN
GlobalData

Abstracts

GenVec Inc (GNVC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Key manufacturing facilities – A list of key manufacturing facilities of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

GenVec Inc (GenVec) focuses on the research and development of gene-based medicine. It develops therapeutics and vaccines using its proprietary adenovector gene delivery platform. The company’s lead product, CGF166 is licensed to Novartis Institutes and is in Phase I/II for the treatment of hearing loss and balance disorders. Its therapeutics portfolio includes novel drugs for cancer, bleeding disorders; vaccines against infectious diseases, including herpes simplex virus (HSV), respiratory syncytial virus (RSV) and malaria. GenVec is also developing vaccines against foot-and-mouth disease (FMD) in cattle. The company also collaborates with leading companies and organizations to leverage its proprietary technology to prevent and treat significant health concerns. GenVec is head quartered in Gaithersburg, Maryland, the US.

GenVec Inc Key Recent Developments

Nov 04,2016: GenVec Reports Third Quarter 2016 Financial Results
Oct 05,2016: GenVec To Present At 2016 Cell & Gene Meeting On The Mesa
Aug 05,2016: GenVec Reports Second Quarter 2016 Financial Results
May 12,2016: GenVec Reports First Quarter 2016 Financial Results
Mar 09,2016: GenVec Reports Fourth Quarter and 2015 Year-End Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

GenVec Inc - Key Facts
GenVec Inc - Key Employees
GenVec Inc - Major Products and Services
GenVec Inc - History
GenVec Inc - Company Statement
GenVec Inc - Locations And Subsidiaries
Head Office

SECTION 2 – COMPANY ANALYSIS

GenVec Inc - Business Description
GenVec Inc - Corporate Strategy
GenVec Inc - SWOT Analysis
SWOT Analysis - Overview
GenVec Inc - Strengths
GenVec Inc - Weaknesses
GenVec Inc - Opportunities
GenVec Inc - Threats
GenVec Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

GenVec Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
GenVec Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
GenVec Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Nov 04, 2016: GenVec Reports Third Quarter 2016 Financial Results
Oct 05, 2016: GenVec To Present At 2016 Cell & Gene Meeting On The Mesa
Aug 05, 2016: GenVec Reports Second Quarter 2016 Financial Results
May 12, 2016: GenVec Reports First Quarter 2016 Financial Results
Mar 09, 2016: GenVec Reports Fourth Quarter and 2015 Year-End Financial Results
Jan 20, 2016: GenVec Provides Investor Update

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

GenVec Inc, Key Facts
GenVec Inc, Key Employees
GenVec Inc, Major Products and Services
GenVec Inc, History
GenVec Inc, Key Competitors
GenVec Inc, Ratios based on current share price
GenVec Inc, Annual Ratios
GenVec Inc, Annual Ratios (Cont.1)
GenVec Inc, Interim Ratios
GenVec Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
GenVec Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
GenVec Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

GenVec Inc, Performance Chart (2012 - 2016)
GenVec Inc, Ratio Charts
GenVec Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
GenVec Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

COMPANIES MENTIONED

Vical Inc
Sanofi
Novavax Inc
NanoBio Corp
Merck & Co Inc
MedImmune LLC
GlaxoSmithKline Plc
Genocea Biosciences Inc
Emergent BioSolutions Inc
Bavarian Nordic A/S